APTALIS PHARMA

aptalis-pharma-logo

Aptalis Pharma (known as Axcan Pharma until May 2011) is a privately-held, leading specialty pharmaceutical company that develops and markets a wide range of products to treat gastrointestinal diseases and disorders, such as inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency. Aptalis hopes to improve the quality of care and health of patients suffering from gastrointestinal diseases and disorders by providing ef... fective therapies for patients and their specialized caregivers. Aptalis was acquired by [TPG Capital](/organization/tpg-capital) in 2008, and it acquired [Eurand](/organization/eurand) in 2010. It [changed its name](http://www.thepressreleasewire.com/client/aptalispharma/release.jsp?actionFor=1437343&releaseSeq=0&year=2011) from Axcan Pharma to Aptalis in May 2011.

#SimilarOrganizations #People #Financial #Website #More

APTALIS PHARMA

Industry:
Biotechnology Developer Platform Therapeutics

Founded:
1982-01-01

Address:
Bridgewater, New Jersey, United States

Country:
United States

Website Url:
http://www.aptalispharma.com

Total Employee:
501+

Status:
Active

Contact:
(800) 678-1605

Total Funding:
170.47 K USD

Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Level 3 Communications Taleo Videotron Bell Canada Reliance Globalcom


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.


Current Advisors List

todd-sisitsky_image

Todd Sisitsky Member of the Board of Directors @ Aptalis Pharma
Board_member

Current Employees Featured

david-w-mims_image

David W. Mims
David W. Mims Executive Vice President and COO @ Aptalis Pharma
Executive Vice President and COO

Founder


frank-verwiel_image

Frank Verwiel

Acquisitions List

Date Company Article Price
2010-12-01 Eurand Eurand acquired by Aptalis Pharma 583 M USD
2001-11-17 Laboratoires Entรฉris Laboratoires Entรฉris acquired by Aptalis Pharma N/A

Official Site Inspections

http://www.aptalispharma.com

  • Host name: 159.180.132.176
  • IP address: 159.180.132.176
  • Location: North Chicago United States
  • Latitude: 42.325
  • Longitude: -87.8561
  • Metro Code: 602
  • Timezone: America/Chicago
  • Postal: 60064

Loading ...

More informations about "Aptalis Pharma" on Search Engine